Maralixibat Impurity 1
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

228113-63-1Maralixibat Impurity 1

● In Stock

Catalogue No.:VE0028042
CAS No.:228113-63-1
Mol. Formula:C25H33FO4S
Mol. Weight:448.59 g/mol

Additional information on CAS 228113-63-1

Parent drug

Maralixibat

IUPAC Name

(4R,5R)-3,3-Dibutyl-7-fluoro-4-hydroxy-5-(4-methoxyphenyl)-2,3,4,5-tetrahydrobenzo[b]thiepine 1,1-dioxide

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O[C@H]([C@@H](C1=CC(F)=CC=C12)C3=CC=C(OC)C=C3)C(CS2(=O)=O)(CCCC)CCCC

InChI

InChI=1S/C25H33FO4S/c1-4-6-14-25(15-7-5-2)17-31(28,29)22-13-10-19(26)16-21(22)23(24(25)27)18-8-11-20(30-3)12-9-18/h8-13,16,23-24,27H,4-7,14-15,17H2,1-3H3/t23-,24-/m1/s1

Description

Maralixibat Impurity 1 (CAS 228113-63-1) is a characterized process-related impurity encountered during synthesis and stability studies. It is monitored in the impurity profile using orthogonal analytical techniques such as HPLC-UV, LC-MS and NMR to confirm identity and quantify levels in bulk drug substance. Forced degradation experiments reveal its appearance under stress conditions, informing root cause analysis and control strategies. Accurate determination supports ICH Q3A compliance, specification setting and development of purification steps. Comprehensive documentation includes retention time, mass spectral fragmentation and spectroscopic assignment to facilitate robust quality control.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url